Cargando…
Olanzapine-Induced Hyperprolactinemia: Two Case Reports
Background: Hyperprolactinemia is a common consequence of treatment with antipsychotics. It is usually defined by a sustained prolactin level above the laboratory upper level of normal in conditions other than that where physiologic hyperprolactinemia is expected. Normal prolactin levels vary signif...
Autores principales: | Barata, Pedro Cabral, Santos, Mário João, Melo, João Carlos, Maia, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680598/ https://www.ncbi.nlm.nih.gov/pubmed/31417404 http://dx.doi.org/10.3389/fphar.2019.00846 |
Ejemplares similares
-
The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
por: Wu, Tzu-Hua, et al.
Publicado: (2021) -
Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022) -
Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011) -
Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
por: He, Sidi, et al.
Publicado: (2020) -
Vitamin D supplementation is effective for olanzapine-induced dyslipidemia
por: Zhou, Zijian, et al.
Publicado: (2023)